New BD Vacutainer Barricor Plasma Blood Collection tube earns CE mark approval

BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it obtained the CE mark in Europe for a next-generation blood separation technology that is designed to enhance sample quality, improve laboratory efficiency and reduce laboratory turnaround time.

BD Vacutainer® Barricor™ tube is a single-use, plastic evacuated tube used to collect, separate, transport and process venous blood specimens to obtain high-quality plasma for in vitro diagnostic use.

The design complements BD Vacutainer® evacuated blood collection tubes, and continues the BD heritage of ensuring best practice in the collection, transportation and processing of blood samples. BD Barricor™ tubes are optimized to deliver a high quality plasma sample by reducing cellular content (vs. plasma gel tubes), as a result of the mechanical separator remaining open throughout the centrifugation cycle. It eliminates gel artifacts which can lead to instrument downtime. These factors together with longer sample stability can significantly improve the sample and laboratory workflow.

According to the American Journal of Clinical Pathology, with 60 to 70 percent of the required information on a patient’s chart coming from laboratory test results, there is a high demand for rapid test turnaround time among clinicians. BD Barricor tubes deliver a faster time-to-result for patients – with no clotting time required and a reduction in centrifugation time of up to 7 minutes, an overall saving in turnaround time of 37 minutes is possible.

“Laboratory technicians are forced to choose between a clean sample with serum and a fast sample with plasma,” said Lisa Nibauer, vice president and general manager of Global Marketing for BD Life Sciences. “BD Barricor tubes eliminate this tradeoff, providing a cleaner and faster plasma sample than current methods.”

The new BD Vacutainer Barricor Plasma Blood Collection tube has a revolutionary separator technology, providing a cleaner plasma sample with less cellular contamination, meaning the sample is more stable and allows a longer window to conduct testing when compared to existing blood separation tubes.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    BD (Becton, Dickinson and Company). (2019, June 20). New BD Vacutainer Barricor Plasma Blood Collection tube earns CE mark approval. News-Medical. Retrieved on June 23, 2024 from https://www.news-medical.net/news/20160302/New-BD-Vacutainer-Barricor-Plasma-Blood-Collection-tube-earns-CE-mark-approval.aspx.

  • MLA

    BD (Becton, Dickinson and Company). "New BD Vacutainer Barricor Plasma Blood Collection tube earns CE mark approval". News-Medical. 23 June 2024. <https://www.news-medical.net/news/20160302/New-BD-Vacutainer-Barricor-Plasma-Blood-Collection-tube-earns-CE-mark-approval.aspx>.

  • Chicago

    BD (Becton, Dickinson and Company). "New BD Vacutainer Barricor Plasma Blood Collection tube earns CE mark approval". News-Medical. https://www.news-medical.net/news/20160302/New-BD-Vacutainer-Barricor-Plasma-Blood-Collection-tube-earns-CE-mark-approval.aspx. (accessed June 23, 2024).

  • Harvard

    BD (Becton, Dickinson and Company). 2019. New BD Vacutainer Barricor Plasma Blood Collection tube earns CE mark approval. News-Medical, viewed 23 June 2024, https://www.news-medical.net/news/20160302/New-BD-Vacutainer-Barricor-Plasma-Blood-Collection-tube-earns-CE-mark-approval.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
BD launches new safety blood collection device in the UK